Clinical Trial Details
| Trial ID: | L6561 |
| Source ID: | NCT06652971 |
| Associated Drug: | Ckd-379 |
| Title: | A Clinical Trial to Evaluate the Food Effect of CKD-379 |
| Acronym: | CKD-379 |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type II Diabetes Mellitus |
| Interventions: | DRUG: CKD-379 |
| Outcome Measures: | Primary: AUCt of CKD-379, Area under the concentration-time curve time zero to time, Pre-dose(0 hour), 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 8, 10, 12, 24, 48 hours]|Cmax of CKD-379, Maximum plasma concentration of the drug, Pre-dose(0 hour), 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 8, 10, 12, 24, 48 hours | |
| Sponsor/Collaborators: | Sponsor: Chong Kun Dang Pharmaceutical |
| Gender: | ALL |
| Age: | ADULT |
| Phases: | PHASE1 |
| Enrollment: | 30 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2024-11-05 |
| Completion Date: | 2024-12-17 |
| Results First Posted: | |
| Last Update Posted: | 2024-12-30 |
| Locations: | Bumin Hospital, Gangseo-gu, Seoul, 07590, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT06652971 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|